Braxia Scientific Corp. (BRAXF)
OTCMKTS · Delayed Price · Currency is USD
0.0013
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
Braxia Scientific Company Description
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.
The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders.
In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform.
The company is headquartered in Toronto, Ontario.
Braxia Scientific Corp.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Roger McIntyre |
Contact Details
Address: 700 Bay Street Toronto, British Columbia M5G 1Z6 Canada | |
| Phone | 416-430-9619 |
| Website | braxiascientific.com |
Stock Details
| Ticker Symbol | BRAXF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| ISIN Number | CA1057361026 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Peter Rizakos | Chief Financial Officer and Director |